A nasal ‘molecular shield’ developed by researchers may soon block mugwort pollen, offering relief from one of the most common hay fever triggers in Europe.

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

Almost two-thirds of the world's population is affected by the monsoon—the annual arrival of intense rains in areas north and ...